Healthcare - Biotechnology - NASDAQ - US
$ 12.0
-6.03 %
$ 69.1 M
Market Cap
-0.35
P/E
Price Target
Average
--12.50%
Revenue Forecast
Estimate
104.86%
EBIT
Estimate
42.49%
Net Income
Estimate
62.86%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Atara Biotherapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ATRA of $10.5 , with forecasts ranging from a low of $3 to a high of $18 .
ATRA Lowest Price Target
Wall Street Target
3 USD
-75.00%
ATRA Average Price Target
Wall Street Target
10.5 USD
-12.50%
ATRA Highest Price Target
Wall Street Target
18 USD
50.00%
REVENUE FORECAST
Revenue Forecast Chart ATRA
EBIT FORECAST
EBIT Forecast Chart ATRA
NET INCOME FORECAST
Net Income Chart ATRA